Hematology
Conference Coverage
Phase III trial: VZV protects auto-HCT patients
ORLANDO – An inactivated VZV vaccine for adults undergoing autologous hematopoietic stem cell transplantation has proven safe and effective.
Guidelines
Guidelines tackle long-term screening, management of myeloma
New myeloma guidelines arrive as “issues of survivorship are becoming increasingly important.”
From the Journals
Thrombotic microangiopathy may signal IV drug abuse
Thrombotic microangiopathy may be triggered by IV drug abuse of extended-release oxymorphone hydrochloride tablets.
From the Journals
Lanadelumab reduced hereditary angioedema attacks by 88%-100%
Lanadelumab reduced attacks of hereditary angioedema with C1 inhibitor deficiency by 88%-100%.
From the Journals
Personal finances affect cancer survivors’ medication use
“Nonelderly cancer survivors were more likely to skip medication [or] delay filling a prescription ... for financial reasons, compared with...
From the Journals
Testosterone Trials’ cardiac, cognitive results disappoint
Testosterone treatment may have beneficial effects on unexplained anemia or bone density, but may increase coronary artery plaque and offer no...
Conference Coverage
Study highlights importance of genotyping in von Willebrand disease
Patients with genetically confirmed von Willebrand disease of this type have a relatively mild clinical phenotype.
Conference Coverage
Boys with severe hemophilia have good physical function
Children with severe hemophilia have generally good self-reported health-related quality of life and physical functioning, but one issue in...
Conference Coverage
ITI protects against bleeding in hemophilia A with factor VIII inhibitors
Immune tolerance induction in hemophilia A patients with inhibitor development against FVIII may provide some protection against bleeding.
Conference Coverage
Study: No link between vaccines, inhibitor development
Pediatric vaccinations given near the time of factor VIII exposure are not linked with inhibitor development in patients with severe hemophilia A...
From the Journals
Sickle cell trait artificially lowers HbA1c
HbA1c levels systematically underestimate glucose levels in black patients who carry the sickle cell trait, researchers say.